Offerings // Immunovant, Inc.

IMVT offering history

Every offering-related filing in Immunovant, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 637 filings back to Jan 23, 2019.

Last executed offering

Dec 12, 2025

424B5 — priced deal (shares or notes)

Last registration (announced)

Nov 9, 2023

S-3ASR — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Dec 12, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 11, 2025	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Jan 24, 2025	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jan 13, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 9, 2023	S-3ASR →	REGISTERED	Automatic shelf registration — effective immediately (large filers)
Sep 29, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 28, 2023	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Sep 28, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Sep 27, 2023	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Sep 26, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 5, 2022	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 2, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 15, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 15, 2021	424B7 →	UPDATE	Resale prospectus — existing holders registering to sell
Jan 14, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 4, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 12, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 3, 2020	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 1, 2020	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Sep 1, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 31, 2020	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Aug 25, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 21, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Aug 12, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Jun 29, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 14, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Apr 14, 2020	S-1MEF →	REGISTERED	S-1MEF registration — capacity to sell shares, not a sale yet
Apr 14, 2020	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Apr 14, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 10, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 10, 2020	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Apr 9, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 8, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Apr 3, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Feb 28, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jan 17, 2020	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
Dec 20, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 2, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 15, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 10, 2019	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)

IMVT offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full IMVT workspace →

IMVT offering FAQ

When did IMVT last execute an offering?

Per SEC filings, Immunovant, Inc.'s most recent priced offering document is a 424B5 filed 2025-12-12. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did IMVT last announce or register an offering?

The most recent registration is a S-3ASR filed 2023-11-09. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.